At Zifam Pinnacle (Myanmar), our purpose is to ensure that every Myanmar patient has access to high-quality, affordable, and innovative healthcare solutions.
To realize this vision, we partner with Delta Biopharma Private Limited, one of India’s most advanced pharmaceutical and nutraceutical manufacturing facilities. Together, we are setting new standards in health product innovation, compliance, and quality assurance.
More than a motto — it’s our mission. At Delta Biopharma, every capsule, every tablet, and every process is built on one promise: to protect and promote global health through precision, purity, and ethical manufacturing.
Global-Class Infrastructure
Strategically located in Tirupati District, Andhra Pradesh, Delta Biopharma operates a 38,657 sq. meter facility designed to accommodate modern oral solid, liquid, and semi-solid production needs. The plant is GMP-certified, US FDA-registered, and holds FSSAI licenses, ensuring total compliance with international regulatory standards.
Key Product Capabilities:
– Tablets & Capsules (Hard Gelatin and Soft Gelatin)
– Oral Liquids & Syrups
– Semi-solids & Dry Granules
– Advanced Nutraceutical Formulations
With proximity to Chennai Port and Tirupati Airport, the facility ensures efficient global and regional distribution, including to Myanmar.
Total Quality Culture
We implement a rigorous Quality Management System (QMS) based on cGMP, ensuring full batch traceability, integrity, and compliance.
Key Highlights:
– Empowered QA & QC teams reporting to top management
– Independent validation and batch release controls
– GLP-compliant laboratories
– Real-time EMS & BMS environmental monitoring
– Controlled processing zones: 18°C to 25°C / 40-60% RH
Every product meets expectations for safety, purity, efficacy, and consistency.
Delta Biopharma’s facility integrates modern clean room architecture, dedicated air handling units, and automated process controls to achieve consistent quality outcomes.
– Positive pressure-controlled zones
– Modular box-in-box facility design
– Fully integrated HVAC, purified water, and ETP systems
– Production capacity: 360M tablets, 360M capsules, 162M softgels, 21.6M syrups/year
Our Formulation Research & Development (FR&D) Division fuels Zifam Pinnacle’s pipeline of new and enhanced products. Our team develops:
– Modified-release systems
– Taste-masked pediatric syrups
– Enhanced bioavailability formulations
– Evidence-based nutraceuticals
We uphold the highest standards in sustainability and employee safety:
– Effluents treated and reused in gardening
– Zero-pollution policy for air emissions
– Routine staff medical exams and training
– Fire safety systems and emergency readiness
Through our partnership, we ensure that:
– Myanmar patients receive internationally benchmarked medicines
– Healthcare professionals have reliable, guideline-compliant therapies
– Public health outcomes are enhanced through consistent product quality
Healthcare Professionals:
Trust in science-backed, regulation-compliant formulations
Distributors & Partners:
Count on reliable delivery, competitive quality, and responsive service
Regulators:
Compliance with WHO-GMP, US FDA, FSSAI, and state health regulations
Investors:
A model of sustainable growth, scalable operations, and product innovation
Zifam Pinnacle (Myanmar) & Delta Biopharma
Delivering Health. Empowering Trust. Inspiring Progress.
